A role for matrix metalloproteinases and tumor host interaction in hepatocellular carcinomas

被引:61
作者
McKenna, GJ [1 ]
Chen, YL [1 ]
Smith, M [1 ]
Meneghetti, A [1 ]
Ong, C [1 ]
McMaster, R [1 ]
Scudamore, CH [1 ]
Chung, SW [1 ]
机构
[1] Univ British Columbia, Vancouver Hosp & Hlth Sci Ctr, Dept Surg, Vancouver, BC V5Z 4E3, Canada
关键词
matrix metalloproteinase; MMP; tissue inhibitor of metalloproteinase; TIMP; hepatocellular carcinoma; metastasis;
D O I
10.1016/S0002-9610(02)00833-4
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Hepatocellular carcinoma (HCC) occur in livers with injury-remodeling, accomplished by enzymes called matrix metalloproteinases (MMP). Metastasis involves basement membrane invasion also caused by MMP activity. Alterations in MMP expression and their endogenous inhibitor (TIMP) may factor in HCC metastasis. Methods: HCC specimens and lymph nodes (n = 7), and normal lymph tissue from organ donors (n = 8), were snap-frozen in liquid nitrogen and the mRNA precipitated. A series of reverse transcription-polymerase chain reactions (RT-PCR) were performed using MMP (MMP2, MMP7, MMP9) primers and TIMP (TIMP1, TIMP2) primers. These were semiquantitatively analyzed by comparing concentration with constitutive GADPH expression. Results: There is an increase in MMP2:TIMP2 mRNA expression ratio in the normal and tumor margin tissue compared to the tumor. There are increases in all MMP and TIMP mRNA expression (except TIMP1) and alterations in ail of the MMP:TIMP expression ratios in the draining lymph node. Conclusions: Alterations exist in MMP2:TIMP2: expression at the margin, and all of the MMPs in the draining lymph nodes. This likely reflects a host-tumor interaction that regulates tumor metastasis. (C) 2002 Excerpta Medica, Inc. All rights reserved.
引用
收藏
页码:588 / 594
页数:7
相关论文
共 37 条
[11]  
Johnatty RN, 1997, J IMMUNOL, V158, P2327
[12]  
LEPPERT D, 1995, J IMMUNOL, V154, P4379
[13]  
LIOTTA LA, 1986, CANCER RES, V46, P1
[14]  
LIOTTA LA, 1993, CANC PRINCIPLES PRAC, P134
[15]  
Määttä M, 2000, CLIN CANCER RES, V6, P2726
[16]  
MARTINEZHERNANDEZ A, 1983, LAB INVEST, V48, P656
[17]   MATRIX METALLOPROTEINASE GENE-EXPRESSION [J].
MATRISIAN, LM .
INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC POTENTIAL, 1994, 732 :42-50
[18]   PRODUCTION AND REGULATION OF GELATINASE-B BY HUMAN T-CELLS [J].
MONTGOMERY, AMP ;
SABZEVARI, H ;
REISFELD, RA .
BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1176 (03) :265-268
[19]   In situ detection of matrix metalloproteinase-2 (MMP2) and the metalloproteinase inhibitor TIMP2 transcripts in human primary hepatocellular carcinoma and in liver metastasis [J].
Musso, O ;
Theret, N ;
Campion, JP ;
Turlin, B ;
Milani, S ;
Grappone, C ;
Clement, B .
JOURNAL OF HEPATOLOGY, 1997, 26 (03) :593-605
[20]   EXPRESSION AND LOCALIZATION OF MATRIX-DEGRADING METALLOPROTEINASES DURING COLORECTAL TUMORIGENESIS [J].
NEWELL, KJ ;
WITTY, JP ;
RODGERS, WH ;
MATRISIAN, LM .
MOLECULAR CARCINOGENESIS, 1994, 10 (04) :199-206